CIK: 1471956 - Address: Eagle Pharmaceuticals, Inc., 50 Tice Blvd., Suite 315, Woodcliff Lake, NJ 07677
12 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

P%ret21104612268410
P%wins90806063434363

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

5/19/17 16:42
5/19/17
EGRXEagle Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsPernock DavidNJOP,Chief P2079.69250361D59138173215787
5/16/17 17:37
5/16/17
EGRXEagle Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsPernock DavidNJOP,Chief P1682.24250391D59138173215787
3/21/17 16:37
3/21/17
EGRXEagle Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsPernock DavidNJOP,Chief P583.98210141D103923711189723712
3/10/17 19:20
3/9/17
EGRXEagle Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsPernock DavidNJOP,Chief P3577.84190New0D1132726-2187211210
12/2/16 11:40
12/2/16
FCSCFibrocell Science, Inc.DEHealthDrugPharmaceutical PreparationsPernock DavidPADOCB,CEOP460.921705090106D-69-86-60-82028-6-145-7-20-19
11/13/15 16:36
11/13/15
FCSCFibrocell Science, Inc.DEHealthDrugPharmaceutical PreparationsPernock DavidPADOCB,CEOP155.0013656D468025-23332114-704-15-59-63-91
8/11/15 16:01
8/11/15
FCSCFibrocell Science, Inc.DEHealthDrugPharmaceutical PreparationsPernock DavidPADOCB,CEOP236.5434753D109072812891-14125-9-12-65-80
5/13/15 16:15
5/13/15
FCSCFibrocell Science, Inc.DEHealthDrugPharmaceutical PreparationsPernock DavidPADOCB,CEOP714.300175149D-241330-8-21-1133-2-3446237-55
12/15/14 16:10
12/12/14
FCSCFibrocell Science, Inc.DEHealthDrugPharmaceutical PreparationsPernock DavidPADOCB,CEOP132.52051833D-33-34-40-6-10-4-131136511313886
11/21/14 16:04
11/20/14
FCSCFibrocell Science, Inc.DEHealthDrugPharmaceutical PreparationsPernock DavidPADOCB,CEOP132.54052228D-46-30-10-16-10-9-6-403-37451110
6/6/14 09:21
6/5/14
FCSCFibrocell Science, Inc.DEHealthDrugPharmaceutical PreparationsPernock DavidPADOCEOP372.9501312523D-58-48-30-48-31-11-11428328-1293
11/21/13 16:40
11/21/13
FCSCFibrocell Science, Inc.DEHealthDrugPharmaceutical PreparationsPernock DavidPADOCEOP373.69010New10D-69-24-25-29-5-2-2697540-29-36

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact